An independent review is currently investigating the exact reasons, but officials and legal teams point to several primary factors behind Christa Pike's botched execution on September 30, 2026:

• Hard-to-Access and Fragile Veins: Pike has a diagnosed blood disorder (thrombocytosis) and unusually small, fragile veins. Her attorneys warned in advance that IV access would be difficult and painful, and medical staff had to move the IV line from her arm to her hand after she complained that her arm felt like it was "about to burst open".

• Potential Misplacement of Drugs: Her defense team and medical analysts suggest the pentobarbital may not have been delivered directly into a proper vein, meaning she did not absorb the intended lethal dose during the first attempt.

• Degraded or Ineffective Medication: Legal filings and reports raised concerns that the pentobarbital used by the state may have been degraded or compromised from being stored too long.

• Protocol and Operational Failures: The state administered a second dose of pentobarbital after the first failed, matching contingency steps, but the protocol lacked any instructions or safety measures for an inmate surviving two doses. This followed a prior botched execution attempt in May 2026 involving Tony Carruthers, where staff also failed to establish complete IV access.

• Leadership and Personnel Issues: Tennessee Department of Correction Commissioner Frank Strada resigned following the incident, facing scrutiny for past execution-related controversies.